Natera, Inc.
NTRA · CIK 0001604821 · Industry not specified
About Natera, Inc.
We are a diagnostics company with proprietary molecular and bioinformatics technology that we are applying to change disease management worldwide. Our cell-free DNA, or cfDNA, technology combines our novel molecular assays, which reliably measure many informative regions across the genome from samples as small as a single cell, with our statistical algorithms that incorporate data available from the broader scientific community to identify genetic variations covering a wide range of serious conditions with high accuracy and coverage.
Business information sourced from SEC annual filing filed Feb 27, 2026. Business descriptions reflect the cited filing and may not describe subsequent changes.
Company identification is based on SEC registration information. Financial figures are sourced from SEC filings.
Financial highlights
Latest qualifying annual SEC observations · USDHistorical financial performance
USD billions · Annual SEC observations · Choose a metric
Each metric uses a consistent SEC accounting concept when available. Fiscal year-end dates may differ across metrics. Negative values are displayed with a minus sign.
Annual financial history
USD · Exact fiscal period ends| Period ended | Revenue | Net income | Operating income | Assets | Liabilities | Cash | Operating cash flow | Net margin |
|---|---|---|---|---|---|---|---|---|
| No qualifying annual financial data available. | ||||||||
A dash indicates unavailable or nonmatching period data. Figures are SEC observations, not estimates.
Company information
- Registered name
- Natera, Inc.
- Ticker symbol
- NTRA
- CIK
- 0001604821
- Exchange
- Not available
- Industry
- Not available
- SEC SIC code
- Not available
- Fiscal year end (MMDD)
- Not available
- Last SEC synchronization
- Not synchronized
Company contact information is drawn from SEC submissions, where reported, and may not reflect current operating locations. Official website, business descriptions and executive details require separate verification.
Latest SEC filings
Browse filings →| Form | Filed | Report period | Official source |
|---|---|---|---|
| No filings imported yet. | |||
Financial data is provided for informational purposes, not investment advice. Observations may include restatements; review original SEC filings before making decisions.